RIGEL PHARMACEUTICALS INC (RIGL) Stock Earnings Estimates
NASDAQ:RIGL • US7665597024
35.46 USD
-1.18 (-3.22%)
At close: Feb 20, 2026
35.46 USD
0 (0%)
After Hours: 2/20/2026, 8:03:10 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 120.2M -19.44% | 116.882M -2.76% | 179.278M 53.38% | 299.06M 66.81% | 284.89M -4.74% | 324.1M 13.76% | 394.25M 21.64% | 370.1M -6.13% | 404.94M 9.41% | 460.72M 13.77% | 452.17M -1.86% | 325.79M -27.95% | |
| EBITDA YoY % growth | -53.3M -579.85% | -19.253M 63.88% | 26.42M 237.23% | 130.42M 393.64% | 97.261M -25.42% | 142.48M 46.49% | 296.82M 108.32% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -54.3M -503.33% | -20.491M 62.26% | 24.192M 218.06% | 128.4M 430.75% | 90.823M -29.27% | 113.67M 25.16% | 149.53M 31.55% | 115.14M -23.00% | 140.17M 21.74% | 167.89M 19.78% | 142.49M -15.13% | 127.3M -10.66% | |
| Operating Margin | -45.17% | -17.53% | 13.49% | 42.93% | 31.88% | 35.07% | 37.93% | 31.11% | 34.62% | 36.44% | 31.51% | 39.07% | |
| EPS YoY % growth | -3.40 -209.09% | -1.50 55.88% | 0.94 162.67% | 6.75 617.80% | 3.87 -42.70% | 4.89 26.59% | 4.98 1.76% | 4.82 -3.12% | 5.76 19.45% | 6.63 15.04% | 5.88 -11.38% | 5.25 -10.59% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.27 58.96% | 0.71 12.52% | 1.01 -69.21% | 1.19 -18.26% | 0.90 -29.02% |
| Revenue Q2Q % growth | 70.075M 21.67% | 60.471M 13.38% | 67.065M -34.05% | 73.44M 5.73% | 78.346M 11.80% |
| EBITDA Q2Q % growth | 25.152M 33.20% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 23.753M 42.62% | 14.382M 12.60% | 21.828M -64.28% | 25.398M -10.63% | 29.172M 22.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.46 108.57% | 0.87 | 0.59 | 67.46% |
| Q2 2025 Q2Q % growth | 3.28 5,566.67% | 2.63 | 0.65 | 24.64% |
| Q1 2025 Q2Q % growth | 0.63 226.00% | 0.09 | 0.54 | 592.43% |
| Q4 2024 Q2Q % growth | 0.80 | 0.48 | 0.32 | 67.95% |
| Q3 2024 Q2Q % growth | 0.70 333.33% | 0.06 | 0.64 | 1,076.54% |
| Q2 2024 Q2Q % growth | -0.06 85.00% | -0.30 | 0.24 | 79.85% |
| Q1 2024 Q2Q % growth | -0.50 37.50% | -0.29 | -0.21 | -70.03% |
| Q4 2023 Q2Q % growth | 0.00 -100.00% | -0.31 | 0.31 | 100.00% |
| Q3 2023 Q2Q % growth | -0.30 72.73% | -0.72 | 0.42 | 58.57% |
| Q2 2023 Q2Q % growth | -0.40 50.00% | -0.80 | 0.40 | 49.72% |
| Q1 2023 Q2Q % growth | -0.80 50.00% | -0.99 | 0.19 | 19.56% |
| Q4 2022 Q2Q % growth | 0.10 107.69% | -1.14 | 1.24 | 108.74% |
| Q3 2022 Q2Q % growth | -1.10 8.33% | -1.37 | 0.27 | 19.78% |
| Q2 2022 Q2Q % growth | -0.80 | -1.25 | 0.45 | 36.08% |
| Q1 2022 Q2Q % growth | -1.60 -172.73% | -1.40 | -0.20 | -14.26% |
| Q4 2021 Q2Q % growth | -1.30 -18.18% | -1.30 | 0.00 | 0.17% |
| Q3 2021 Q2Q % growth | -1.20 -50.00% | -1.02 | -0.18 | -18.04% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -1.17 | 0.37 | 31.40% |
| Q1 2021 Q2Q % growth | 2.20 69.23% | 0.05 | 2.15 | 4,365.55% |
| Q4 2020 Q2Q % growth | -1.10 | -1.16 | 0.06 | 5.13% |
| Q3 2020 Q2Q % growth | -0.80 | -1.24 | 0.44 | 35.56% |
| Q2 2020 Q2Q % growth | -1.00 | -1.36 | 0.36 | 26.52% |
| Q1 2020 Q2Q % growth | 1.30 | 1.34 | -0.04 | -3.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 69.462M 25.59% | 63.117M | 6.345M | 10.05% |
| Q2 2025 Q2Q % growth | 101.685M 176.01% | 90.726M | 10.959M | 12.08% |
| Q1 2025 Q2Q % growth | 53.333M 80.58% | 44.752M | 8.581M | 19.17% |
| Q4 2024 Q2Q % growth | 57.596M 60.92% | 52.766M | 4.83M | 9.15% |
| Q3 2024 Q2Q % growth | 55.307M 96.58% | 42.766M | 12.541M | 29.32% |
| Q2 2024 Q2Q % growth | 36.841M 37.03% | 34.088M | 2.753M | 8.08% |
| Q1 2024 Q2Q % growth | 29.534M 13.29% | 31.91M | -2.376M | -7.45% |
| Q4 2023 Q2Q % growth | 35.792M -30.20% | 34.784M | 1.008M | 2.90% |
| Q3 2023 Q2Q % growth | 28.134M 25.54% | 27.745M | 389K | 1.40% |
| Q2 2023 Q2Q % growth | 26.886M -9.84% | 26.218M | 668K | 2.55% |
| Q1 2023 Q2Q % growth | 26.07M 55.73% | 24.554M | 1.516M | 6.17% |
| Q4 2022 Q2Q % growth | 51.28M 151.25% | 28.527M | 22.753M | 79.76% |
| Q3 2022 Q2Q % growth | 22.41M 4.04% | 23.062M | -652K | -2.83% |
| Q2 2022 Q2Q % growth | 29.82M 13.51% | 24.128M | 5.692M | 23.59% |
| Q1 2022 Q2Q % growth | 16.74M -79.34% | 17.895M | -1.155M | -6.45% |
| Q4 2021 Q2Q % growth | 20.41M 10.62% | 22.337M | -1.927M | -8.63% |
| Q3 2021 Q2Q % growth | 21.54M 17.13% | 24.033M | -2.493M | -10.37% |
| Q2 2021 Q2Q % growth | 26.27M 63.98% | 20.777M | 5.493M | 26.44% |
| Q1 2021 Q2Q % growth | 81.02M 45.30% | 31.672M | 49.348M | 155.81% |
| Q4 2020 Q2Q % growth | 18.45M | 18.463M | -13K | -0.07% |
| Q3 2020 Q2Q % growth | 18.39M | 17.58M | 810K | 4.61% |
| Q2 2020 Q2Q % growth | 16.02M | 14.024M | 1.996M | 14.23% |
| Q1 2020 Q2Q % growth | 55.76M | 57.841M | -2.081M | -3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.09% | 14.42% | -0.53% | 19.02% |
| Revenue | 1.14% | 3.19% | 0.27% | 4.3% |